Diseases, Conditions, Syndromes

Am I immune to COVID-19 if I have antibodies?

Perhaps the most important question now about COVID-19 is the degree to which a prior infection protects from a second infection by the new coronavirus. This affects vaccine development and herd immunity and is something ...

Diseases, Conditions, Syndromes

Q&A: What it will take to produce a COVID-19 vaccine

Immunology and infectious disease expert Joel Ernst, M.D., addresses key questions about how vaccine development works and why vaccines are especially important in the case of COVID-19.

Medical research

What the phase 1 trials of the first COVID-19 vaccine really mean

Early morning on May 18, Moderna, a biotechnology company, revealed the preliminary findings for the much anticipated phase I trial of an mRNA COVID-19 vaccine. The information sent Moderna's stock soaring by more than 20% ...

Medical research

Antibody study sheds light on COVID-19 immunity

New research from Emory University indicates that nearly all people hospitalized with COVID-19 develop virus-neutralizing antibodies within six days of testing positive. The findings will be key in helping researchers understand ...

Diseases, Conditions, Syndromes

Experts outline plan for COVID-19 vaccines

Unprecedented collaboration and resources will be required to research and develop safe and effective vaccines for COVID-19 that can be manufactured and delivered in the scale of billions of doses to people globally.

Diseases, Conditions, Syndromes

Germany warns vaccine could take 'years'

Germany's health minister said developing a vaccine for the coronavirus could take "years", after Donald Trump predicted it could be achieved by the end of 2020.

Vaccination

Lab developing a COVID-19 vaccine aimed at reaching billions

After cities shut down and citizens were urged to stay home to slow the spread of COVID-19, scientists in major cities like Boston were suddenly far removed from their labs. At MIT, on-campus research was ramped down, reduced ...

page 19 from 35